Rockwell Medical (RMTI) Treasury Shares (2016 - 2026)
Rockwell Medical (RMTI) posted Treasury Shares of $1.1 million for Q1 2026, down 7.2% on a QoQ basis from $1.2 million in Q4 2025, and up 180.0% year-over-year from $383326.0 in Q1 2025.
Rockwell Medical (RMTI) Treasury Shares (2016 - 2026) Analysis & Trends
Rockwell Medical's Treasury Shares history runs 11 years deep, the most recent figure standing at $1.1 million for Q1 2026.
- Quarterly Treasury Shares rose 180.0% year-over-year to $1.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.1 million (up 180.0% YoY) and the FY2025 annual result came in at $1.2 million, up 97.95% from the prior year.
- Treasury Shares was $1.1 million for Q1 2026 at Rockwell Medical, down from $1.2 million in the prior quarter.
- Across five years, Treasury Shares topped out at $1.2 million in Q2 2025 and bottomed at $891.0 in Q3 2024.
- A 5-year average of $464398.8 and a median of $313065.0 in 2023 frame the typical range for Treasury Shares.
- Annual changes were most pronounced in 2024 — Treasury Shares sank 99.69% — and 2025, when it surged 130838.27%.
- Rockwell Medical's Treasury Shares stood at $125000.0 in 2022, then jumped by 107.11% to $258885.0 in 2023, then soared by 125.7% to $584309.0 in 2024, then soared by 97.95% to $1.2 million in 2025, then declined by 7.2% to $1.1 million in 2026.
- Business Quant data shows RMTI's Treasury Shares at $1.1 million in Q1 2026, $1.2 million in Q4 2025, and $1.2 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 62.52 Mn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 107.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 11.29 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 313.27 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 5.44 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 1.01 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Rockwell Medical | 25.77 Mn | 1.88 Mn | 2.90 Mn | 1.07 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.07 Mn |
| Mar 31, 2026 | 1.07 Mn |
| Dec 31, 2025 | 1.16 Mn |
| Dec 31, 2025 | 1.16 Mn |
| Sep 30, 2025 | 1.17 Mn |
| Sep 30, 2025 | 1.17 Mn |
| Jun 30, 2025 | 1.17 Mn |
| Jun 30, 2025 | 1.17 Mn |
| Mar 31, 2025 | 383,326.00 |
| Mar 31, 2025 | 383,326.00 |
| Dec 31, 2024 | 584,309.00 |
| Dec 31, 2024 | 584,309.00 |
| Sep 30, 2024 | 891.00 |
| Sep 30, 2024 | 891.00 |
| Jun 30, 2024 | 534,309.00 |
| Jun 30, 2024 | 534,309.00 |
| Mar 31, 2024 | 441,218.00 |
| Mar 31, 2024 | 441,218.00 |
| Dec 31, 2023 | 258,885.00 |
| Dec 31, 2023 | 258,885.00 |